Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Novartis Novartis Vaccines |
---|---|
Information provided by: | Novartis |
ClinicalTrials.gov Identifier: | NCT00329966 |
To evaluate the antibody response to each influenza vaccine antigen when administering a single dose to subjects aged 18 years and over
Condition | Intervention | Phase |
---|---|---|
Influenza |
Biological: Surface Antigen, Inactivated, Influenza (form.2006-07) |
Phase II |
Study Type: | Interventional |
Study Design: | Prevention, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of a Commercially Available Surface Antigen, Inactivated, Influenza Vaccine, Formulation 2006-2007, When Administered to Non-Elderly Adult and Elderly Subjects |
Estimated Enrollment: | 100 |
Study Start Date: | June 2006 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Italy | |
Dipartimento di Medicina e Scienze dell’Invecchiamento Università G. D’AnnunzioVia dei Vestini | |
Chieti, Italy, 66100 | |
Ufficio Igiene e Sanità Pubblica di Lanciano, ASL, Via S. Spaventa, 37 | |
Lanciano, Italy |
Study Chair: | Novartis Vaccines - Drug Information Services | Novartis Vaccines & Diagnostics |
Study ID Numbers: | V71P4S, Eudract no.2006-000609-43 |
Study First Received: | May 23, 2006 |
Last Updated: | September 13, 2006 |
ClinicalTrials.gov Identifier: | NCT00329966 |
Health Authority: | Italy: Ministry of Health |
Influenza adult elderly vaccine |
Virus Diseases Respiratory Tract Diseases Respiratory Tract Infections Influenza, Human Orthomyxoviridae Infections |
RNA Virus Infections |